| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(86)90486-9 |
| P698 | PubMed publication ID | 3524221 |
| P2093 | author name string | S A Lerner | |
| G J Matz | |||
| B A Schmitt | |||
| R Seligsohn | |||
| P433 | issue | 6B | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amikacin | Q408529 |
| gentamicin | Q422482 | ||
| ototoxicity | Q1351381 | ||
| P304 | page(s) | 98-104 | |
| P577 | publication date | 1986-06-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. | |
| P478 | volume | 80 |
| Q50483980 | A Proposed Protocol for Monitoring Ototoxicity in Patients who Take Cochleo- or Vestibulotoxic Drugs |
| Q33905258 | A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation |
| Q44580544 | Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats |
| Q52424747 | Amikacin once daily: a new dosing regimen based on drug pharmacokinetics. |
| Q38919674 | Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review |
| Q39634450 | Aminoglycoside antibiotics in clinical use. |
| Q44436107 | Aminoglycoside dosages and nephrotoxicity: quantitative relationships |
| Q38676819 | Aminoglycoside-induced hearing loss in humans |
| Q37224123 | Aminoglycoside-induced vestibular injury: maintaining a sense of balance |
| Q72336039 | Aminoglycosides |
| Q39608639 | Aminoglycosides: current role in antimicrobial therapy |
| Q98170152 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis |
| Q44529108 | Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. |
| Q30838132 | Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up |
| Q47211006 | Bayesian pharmacokinetics of gentamicin in a haemodialysis population |
| Q34461015 | Beetroot (Beta vulgaris L.) extract ameliorates gentamicin-induced nephrotoxicity associated oxidative stress, inflammation, and apoptosis in rodent model |
| Q33182992 | Chronic experimental bacteremia in Yucatan micropigs |
| Q37079612 | Cilia-Associated Genes Play Differing Roles in Aminoglycoside-Induced Hair Cell Death in Zebrafish |
| Q30447637 | Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention |
| Q42074674 | Clinical Predictors of Streptomycin-Vestibulotoxicity |
| Q40730362 | Cost considerations in therapeutic drug monitoring of aminoglycosides |
| Q64901667 | Cytoskeletal protein mRNA expression in the chick utricle after treatment in vitro with aminoglycoside antibiotics: effects of insulin, iron chelators and cyclic nucleotides. |
| Q43685861 | Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats |
| Q40594113 | Experimental, clinical and preventive aspects of ototoxicity |
| Q36460134 | Frequency and Demographics of Gentamicin Use. |
| Q30371562 | Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms. |
| Q50457858 | Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine |
| Q38623078 | In Vitro Activity of Gentamicin-Loaded Bioabsorbable Beads against Different Microorganisms |
| Q39566914 | Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization |
| Q47608948 | N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients |
| Q24599985 | New developments in aminoglycoside therapy and ototoxicity |
| Q38384722 | New treatment options for hearing loss. |
| Q38727368 | Ototoxicity and cancer therapy |
| Q30447867 | Ototoxicity in dogs and cats |
| Q33860155 | Outcome assessment of minimizing vancomycin monitoring and dosing adjustments |
| Q39359403 | Patients' safety: is there a systemic release of gentamicin by gentamicin-coated tibia nails in clinical use? |
| Q73167979 | Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside |
| Q35834985 | Prevention of hepatorenal toxicity with Sonchus asper in gentamicin treated rats |
| Q35254820 | Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats |
| Q72370279 | Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz |
| Q33977062 | Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity |
| Q44692640 | Protective effect of diallyl sulfide on oxidative stress and nephrotoxicity induced by gentamicin in rats |
| Q38070006 | Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). |
| Q46978867 | Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies. |
| Q30474223 | Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways |
| Q36969106 | Susceptibility genes for gentamicin-induced vestibular dysfunction. |
| Q59812421 | The Inner Ear Heat Shock Transcriptional Signature Identifies Compounds That Protect Against Aminoglycoside Ototoxicity |
| Q61814532 | The role of retrograde intraflagellar transport genes in aminoglycoside-induced hair cell death |
| Q39558431 | Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides |
| Q35094539 | Using the zebrafish lateral line to uncover novel mechanisms of action and prevention in drug-induced hair cell death |
Search more.